Tag Archives: Novo Nordisk
Novo Nordisk Prosperity: Wegovy and Ozempic In The Spotlight
The Resilient Rise of Wegovy and Ozempic The Danish pharmaceutical company, Novo Nordisk (NVO), has recently updated its financial outlook for the year due to the increasing demand for its weight loss drug, Wegovy, and diabetes medication, Ozempic. These drugs are administered through weekly injections and have been sought after by patients for their significant […]